Which is better for cholesterol: Crestor (rosuvastatin) or Lipitor (atorvastatin)?
Both Crestor and Lipitor are statins used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk. “Better” usually means either (1) getting a stronger LDL reduction at typical doses or (2) tolerating the medication with fewer side effects for a specific person.
In practice, many clinicians choose based on:
- How much LDL reduction is needed
- Prior statin response (and side effects)
- Other health factors (kidney disease, liver disease, drug–drug interactions)
- Dose equivalence and intensity (high-intensity vs moderate-intensity)
How do LDL-lowering strengths compare?
At equivalent “strength,” rosuvastatin and atorvastatin can both substantially lower LDL. Rosuvastatin is often perceived as slightly more potent per milligram, which can matter if a patient needs a larger LDL drop. Atorvastatin is widely used and has a long track record, including in large cardiovascular outcomes trials. The “better” choice depends less on the brand name and more on the dose and whether the LDL target is reached.
If your goal is maximum LDL reduction, your clinician may pick whichever statin can hit your target with the lowest risk of side effects for you.
Which one tends to have fewer side effects?
Common statin side effects include muscle aches (myalgia), elevated liver enzymes, and rarely more serious muscle injury. Which is “better” for side effects varies by person.
Some patients tolerate one statin better than the other. If you’ve had muscle symptoms or lab abnormalities on one medication, switching to the other (often at a lower dose or different dosing strategy) can be an effective approach.
Dose and intensity: what matters more than brand choice
Most comparisons boil down to how you’ll be dosed:
- Moderate-intensity regimens typically aim for a moderate LDL reduction.
- High-intensity regimens aim for the largest typical LDL reduction and are usually chosen for people at higher cardiovascular risk.
Your doctor can match the regimen intensity to your risk level and LDL goal.
What about drug interactions and other conditions?
Choosing between Crestor and Lipitor can depend on:
- Kidney function (this can influence how aggressively rosuvastatin is used)
- Liver disease or prior abnormal liver tests
- Other medicines that interact with statins (interaction risk can change by the specific statin and the other drugs)
If you take medications for HIV/HCV, certain antibiotics/antifungals, transplant drugs, or other interacting therapies, your clinician may favor one option over the other to reduce interaction risk.
If you don’t reach your LDL goal on one, what’s next?
If LDL is not at goal after a statin trial, clinicians often:
- Increase to a higher dose (if tolerated)
- Switch to the other statin
- Add another LDL-lowering therapy (for example, ezetimibe or a PCSK9 inhibitor in higher-risk cases)
The “better” strategy is the one that gets you to your LDL target while you can stay on it consistently.
How to decide quickly with your prescriber
Bring your questions in terms of your situation:
- What LDL reduction do I need?
- What starting dose and intensity are you targeting?
- Given my other medications and kidney/liver status, which is safer for me?
- If I get muscle symptoms, would we switch from Lipitor to Crestor (or vice versa)?
If you tell me your age, your most recent LDL number, and any prior statin side effects or current medications, I can help you frame a more specific “which is better for you” comparison.